• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Psychiatry

Inflammatory markers associated with depressive symptoms and suicidality

byJack LennonandAlex Chan
November 14, 2020
in Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Coheritability was found between individual depressive symptoms and C-reactive protein (CRP) levels.

2. There may be a causal association of CRP and depression with metabolic dysregulation.

3. Interleukin 6 signaling was associated with suicidality.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Inflammation, C-reactive protein (CRP), and interleukin 6 (IL-6) are implicated in depressive symptoms and suicidal behaviors. Much of what is known about the biological aspects of depression are difficult to translate to clinical practice. The degree to which genetics impact these associations and resulting depressive phenotypes continues to be questioned. This study aimed to determine whether or not there is a shared genetic background between inflammatory pathways in individuals with depressive symptoms.

This genome-wide association study (GWAS) utilized data from Europe with between 117,907 and 500,199 participants, depending on the variable of interest. Findings suggested coheritability between individual depressive symptoms and CRP levels, possibly stemming from the causal association of metabolic dysregulation with feelings of inadequacy, changes in appetite, anhedonia, and fatigue. IL-6, a marker for inflammation, was found to be associated with suicidality, which aligns with suicidal individuals who also present with inflammatory conditions. Suicidal behavior originates from complex sequence of biological events, which are recursive in nature but may harbor the potential for future treatments. Study findings identify possible biomarkers associated with suicidality, and suggest a possible role for anti-inflammatory approaches to treatment as a useful strategy for these populations.

Click to read the study in JAMA Psychiatry

RELATED REPORTS

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

Physical activity may be helpful in treating depressive symptoms in children and adolescents

ECT may be more effective than ketamine in improving depression severity

Relevant Reading: Genome-Wide Association Analyses Identify 44 Risk Variants and Refine the Genetic Architecture of Major Depression

In-Depth [ retrospective cohort]:

This genetic correlation and two-sample mendelian randomization study utilized large-scale GWAS data sources from November 2019 to April 2020. Participant count depended on the variable of interest. Serum CRP levels from 204,402 individuals, 500,199 individuals with depression, 322,154 with body-mass index (BMI), 253,280 with height and soluble IL-6 receptor (sIL-6R) protein levels, 386,533 with insomnia, and 117,907 with completed Patient Health Questionnaires 9 (PHQ-9). Linkage disequilibrium score (LDSC) regression and MR analyses allowed for the dissection of the relationships between metabolic factors, depressive symptoms, and inflammation. The LDSC regression also allows for the assessment of single-nucleotide variants (SNV)-based phenotype heritability (h2) and coheritability between two traits. LDSC was used to estimate h2 and CRP-level genetic correlations between MD, BMI, and height.

SNV-based heritability was low for depressive symptoms (h2 range = 0.0143 to 0.0631), CRP levels (h2 = 0.0941), and MD (h2 range = 0.0599 to 0.0723). However, BMI (h2 = 0.1297) and height (h2 = 0.3120) demonstrated higher levels of heritability. Suicidality h2 was lower than the suggested threshold of z>4, which could potentially reflect unreliability of estimates of genetic correlation. There was evidence for genetic correlation between CRP levels and all depressive symptoms (genetic correlation range = 0.152 to 0.362). BMI-depressive symptom estimates were also associated with CRP-depressive symptom estimates (Pearson r = 0.89, Spearman ρ = 0.92, p = 0.001). MR analyses of CRP levels did not demonstrate associations with depressive symptoms, insomnia, or MD. However, there was some evidence of associations with appetite changes, fatigue, and psychomotor changes, but these could not be replicated in weight median MR. MR analyses were, however, able to observe an association of suicidality with upregulated IL-6 signaling (estimate [SE] = 0.035 [0.010]; FDR plus Bonferroni P = 0.01), but IL-6 signaling was not associated with MD, insomnia, or other depressive symptoms.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: depressionpsychiatrysuicide
Previous Post

Association between antipsychotic use and ischemic heart disease found in women

Next Post

Adjuvant radiotherapy may worsen outcomes compared to salvage radiotherapy post radical prostatectomy

RelatedReports

The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Fight Against Childhood Obesity, Prioritizing Mental Health, The Rise of XBB1.5, and Choose Your Chocolates Wisely

January 25, 2023
Certain financial incentive programs may promote increased physical activity
Chronic Disease

Physical activity may be helpful in treating depressive symptoms in children and adolescents

January 18, 2023
Quick Take: Effect of Developmentally Adapted Cognitive Processing Therapy for Youth With Symptoms of Posttraumatic Stress Disorder After Childhood Sexual and Physical Abuse
Psychiatry

ECT may be more effective than ketamine in improving depression severity

January 18, 2023
Children’s hospital visits for suicide ideation and attempts are increasing
Psychiatry

Loneliness is associated with new onset mental health problems

January 13, 2023
Next Post
Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Adjuvant radiotherapy may worsen outcomes compared to salvage radiotherapy post radical prostatectomy

American Academy of Pediatrics recommends standards for adverse event disclosures

2 Minute Medicine Rewind November 16, 2020

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease

Comparison of life and healthy life expectancies between IBD patients and the general population

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options